Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Shilpa Sengupta"'
Autor:
Mitali Chatterjee, Ritika Sengupta, Debanjan Mukhopadhyay, Shibabrata Mukherjee, Aishwarya Dighal, Srija Moulik, Shilpa Sengupta
Publikováno v:
Indian Journal of Dermatology, Vol 65, Iss 6, Pp 452-460 (2020)
Kala-azar, commonly known as visceral leishmaniasis (VL), is a neglected tropical disease that has been targeted in South Asia for elimination by 2020. Presently, the Kala-azar Elimination Programme is aimed at identifying new low-endemic foci by act
Externí odkaz:
https://doaj.org/article/601b4fbc4da440b988e5e6f1827fcfcc
Autor:
Shilpa Sengupta, Mitali Chatterjee
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 11 (2021)
Background The assessment of chemotherapeutic responses in Post Kala-azar Dermal Leishmaniasis (PKDL), especially its macular form is challenging, emphasizing the necessity for ‘test of cure’ tools. This study explored the diagnostic and prognost
Externí odkaz:
https://doaj.org/article/d7de19ca73974424a8c3fb38fb4b0ad2
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
With the Visceral Leishmaniasis/Kala-azar Elimination Program in South Asia in its consolidation phase, the focus is mainly on case detection, vector control, and identifying potential sources of infection. Accordingly, emphasis is presently on curbi
Externí odkaz:
https://doaj.org/article/6637df1a130345ef9ed4f7c4e429b822
Publikováno v:
Drug and chemical toxicology.
Methotrexate (MTX) is currently used as first-line therapy for autoimmune diseases like rheumatoid arthritis, psoriasis, and systemic lupus erythematous. However, its use is limited by its hepatotoxic potential. Epigallocatechin-3-gallate (EGCG), an
Autor:
Srija Moulik, Mitali Chatterjee, Shibabrata Mukherjee, Debanjan Mukhopadhyay, Shilpa Sengupta, Aishwarya Dighal, Ritika Sengupta
Publikováno v:
Indian Journal of Dermatology, Vol 65, Iss 6, Pp 452-460 (2020)
Indian Journal of Dermatology
Indian Journal of Dermatology
Kala-azar, commonly known as visceral leishmaniasis (VL), is a neglected tropical disease that has been targeted in South Asia for elimination by 2020. Presently, the Kala-azar Elimination Programme is aimed at identifying new low-endemic foci by act
Autor:
Mitali Chatterjee, Shilpa Sengupta
Publikováno v:
PLoS Neglected Tropical Diseases, Vol 15, Iss 11 (2021)
PLoS Neglected Tropical Diseases, Vol 15, Iss 11, p e0009906 (2021)
PLoS Neglected Tropical Diseases
PLoS Neglected Tropical Diseases, Vol 15, Iss 11, p e0009906 (2021)
PLoS Neglected Tropical Diseases
Background The assessment of chemotherapeutic responses in Post Kala-azar Dermal Leishmaniasis (PKDL), especially its macular form is challenging, emphasizing the necessity for ‘test of cure’ tools. This study explored the diagnostic and prognost
Publikováno v:
Frontiers in Cellular and Infection Microbiology, Vol 11 (2021)
With the Visceral Leishmaniasis/Kala-azar Elimination Program in South Asia in its consolidation phase, the focus is mainly on case detection, vector control, and identifying potential sources of infection. Accordingly, emphasis is presently on curbi
Publikováno v:
Frontiers in Cellular and Infection Microbiology
With the Visceral Leishmaniasis/Kala-azar Elimination Program in South Asia in its consolidation phase, the focus is mainly on case detection, vector control, and identifying potential sources of infection. Accordingly, emphasis is presently on curbi